C-Rel, a member of the NF-κB family, was aberrantly activated or expressed in human breast cancers, as well as in other solid and hematopoietic malignancies (Cogswell et al., 2000; Sovak et al., 1997). Here, NFKB1 is linked to breast carcinoma.